RTNS 2012

Recent articles

Spectrum from The Transmitter.

Better tools needed to assess clinical trials

The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.

By Emily Singer
14 May 2012 | 6 min read
Spectrum from The Transmitter.

Trials and tribulations

Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.

By Emily Singer
11 May 2012 | 3 min read
Spectrum from The Transmitter.

Compensatory mechanisms

Identifying genetic and other factors that protect children at risk of autism from developing the disorder could provide new avenues for treatment.

By Emily Singer
8 May 2012 | 3 min read
Spectrum from The Transmitter.

Debate over quality of adult-derived stem cells rages on

As the use of induced pluripotent stem cells grows, researchers are searching for ways to make them behave more predictably. 

By Emily Singer
7 May 2012 | 8 min read
Spectrum from The Transmitter.

Complex case

Multiple levels of complexity make it challenging to develop drugs to treat autism.

By Emily Singer
4 May 2012 | 3 min read
Spectrum from The Transmitter.

Fast-forward

In the last three years, autism researchers have gone from sequencing single genes to whole exomes, as highlighted at the Translational Neuroscience Symposium in Switzerland last week.

By Emily Singer
27 April 2012 | 3 min read

Explore more from The Transmitter

Grid of black-and-white headshots of neuroscience trainees.

‘A gut punch:’ How U.S. neuroscience trainees are grappling with diversity-based funding flux

Ten trainees spoke with The Transmitter about how the precarious state of U.S. federal funding is affecting their research and career plans.

By Calli McMurray, Angie Voyles Askham, Claudia López Lloreda
14 February 2025 | 2 min read
A brain made up of a matrix of small, predominately blue dots.

‘Bioethics and Brains: A Disciplined and Principled Neuroethics,’ an excerpt

In their new book, published earlier this week, Giordano and Shook examine how ethics can guide neuroscience research and its real-world applications.

By James Giordano, John Shook
14 February 2025 | 6 min read
A young child in a blue shirt sits in a red chair and speaks to an adult at the edge of the frame.

AI tool estimates social ability by analyzing speech

The system’s code and training data—drawn from one of the largest databases of speech recordings from autistic people—are openly available.

By Charles Q. Choi
13 February 2025 | 5 min read